SAN DIEGO--(BUSINESS WIRE)--Artes Medical, Inc. (Nasdaq:ARTE), a medical technology company focused on developing, manufacturing and commercializing a new category of aesthetic injectable products for men and women, today announced the Company is continuing and expanding programs throughout the country of peer-to-peer physician training sessions with ArteFill, the first and only FDA-approved non-resorbable dermal filler for the treatment of smile lines. These programs are conducted by leading dermatologists and plastic surgeons.
